Please try another search
Kadimastem Ltd is an Israel-based regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The Company produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.
| Name | Age | Since | Title |
|---|---|---|---|
| Benjamin Reubinoff | - | - | Member of Scientific Advisory Board |
| Eran Israel Iohan | 51 | 2022 | External Director |
| Ronen Twito | 49 | 2020 | CEO & Executive Chairman |
| Jeanne F. Loring | - | - | Member of Scientific Advisory Board |
| Olivier Samuel | 51 | 2020 | VP of Research and Development & Director |
| Tamir Ben Hur | - | - | Member of Scientific Advisory Board |
| Liora Oren | 48 | 2022 | Independent External Director |
| Joseph Itskovitz-Eldor | 78 | 2018 | Member of Scientific Advisory Board |
| Danielle Melloul | - | - | Member of Scientific Advisory Board |
| Tamar Galili | 53 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review